We’re starting a new week on an upbeat note, with news from biotech companies large and small on how they are making a difference in the COVID-19 fight. As BIO’s Chair Dr. Jeremy Levin says, this is the industry’s “finest hour.” Here are about 680 words, or 3 minutes, 20 seconds.

The bad news? There’s been a detection of bird flu in the United States. The even worse news? Dolly Parton is unaware that over 50+ biotech innovators are working around the clock to beat COVID-19. Help us spread the word by RETWEETING our message to Dolly! You can do so by clicking here.As for the good news, we know how to protect against animal diseases. And we’re very close to COVID-19 treatments and vaccines. Here’s a quick 662 words, or about 3 minutes, 20 seconds.

Today marks 100 days since China announced the detection of the coronavirus (H/T Axios/The Guardian).  We also have a milestone to report: the BIO Coronavirus Hub has 1,000 users. More on that, plus how we can ensure the continuity of the food supply chain, in around 900 words, or 4-and-a-half minutes.P.S. We're thinking of our readers celebrating Passover, Holy Week, and Easter. With so much going on in our industry, we are continuing business as usual at Good Day BIO in the coming days, but we are wishing you all a joyous holiday and hope you enjoy time with your families, virtually.

Congratulations to the several BIO members who were included in Endpoints News’ 20 Under 40 in Biopharma! We’re proud to be working with so many next-generation biotech leaders.  Today, we take a closer look at how animal biotech policy can help us fight coronavirus, as well as answer some of your questions about antibodies, in about 860 words, just over 4 minutes.

It’s World Health Day, a public health awareness day promoted by the World Health Organization (WHO)—and this year’s theme celebrates nurses and midwives, many of whom are caring for patients on the frontlines of the COVID-19 pandemic. We’re thinking of you today, and every day, as we race to find therapeutics and vaccines and deliver diagnostics and other tools and supplies for you to do your jobs safely. Today, we’re looking at one example of how international collaboration is doing just that, plus, why you don’t need to worry about running out of food. Here are 850 words, just over 4 minutes.

It’s a new week. Today, we’re taking a look at how several BIO members are collaborating on COVID-19—from developing innovative science to sending their employees to the front lines of the fight. Here are about 720 words, or 3 minutes, 30 seconds.

It’s the weekend, and we hope you are finding a little rest, relaxation, and joy at home.  In today’s Special Weekend Edition of Good Day BIO, we’re taking a brief break from all the news surrounding COVID-19 to share the latest episode of the I AM BIO podcast: Sickle Cell Saviors. Sickle cell disease is an inherited red blood cell disease that can cause debilitating pain and lifelong complications. In the United States, the disease disproportionately affects African Americans.  In November, the Food and Drug Administration (FDA) approved Global Blood Therapeutics’ Oxbryta, the first drug that attacks the underlying cause of sickle cell disease.  In this episode, you'll hear from three inspiring guests: Global Blood Therapeutics CEO Dr. Ted Love, who talks about the history of the disease and how GBT’s diverse, majority-minority workforce drove this groundbreaking discovery. Mapillar Dahn, Founder of the My Three Sicklers Sickle Cell Foundation, who has three daughters born with the disease. She talks about the realities of discrimination in U.S. health systems. Dr. Helen Torley, CEO of Halozyme and the leader of BIO’s Workforce Development, Diversity and Inclusion Committee, who explains how BIO is working to create a new generation of diverse leadership in the biotech industry, and how the sickle cell breakthrough shows why it's important for biotech workforces to represent the communities they serve. Why it matters: Whether it’s fighting Covid-19 or looking for innovative ways to treat other devastating diseases, providing hope and saving lives is what the men and women of the biopharmaceutical industry strive for every day. Listen to the full podcast by visiting www.bio.org/podcast or wherever you get your podcast fix including Apple, Google, and Spotify.  Learn more about why diversity matters in biotech at www.rightmixmatters.org.   Learn more about MTS Sickle Cell Foundation at www.mythreesicklers.org.   We’ll be back on Monday with the news.